Isabella Pugliesi

发表

Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo.

F. Da Settimo, S. Taliani, G. Nesi, 2013, ACS medicinal chemistry letters.

3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.

E. Novellino, B. Cosimelli, G. Greco, 2012, Journal of medicinal chemistry.

Template for the Design of Highly Selective A 2 B Adenosine Receptor Antagonists

E. Novellino, B. Cosimelli, G. Greco, 2012 .

Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.

E. Novellino, F. Da Settimo, S. Taliani, 2012, European journal of medicinal chemistry.

Derivatives of Benzimidazol‐2‐ylquinoline and Benzimidazol‐2‐ylisoquinoline as Selective A1 Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility

E. Novellino, B. Cosimelli, G. Greco, 2011, ChemMedChem.

Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator protein.

E. Novellino, G. Greco, F. Da Settimo, 2012, Journal of medicinal chemistry.

3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.

F. Da Settimo, S. Taliani, M. Trincavelli, 2011, ACS chemical neuroscience.

a ] benzimidazol-4 ( 10 H )-one , a Novel Adenosine Receptor Antagonist with A 2 A-Mediated Neuroprotective Effects

S. Taliani, M. Trincavelli, C. Martini, 2011 .

Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.

F. Da Settimo, S. Taliani, I. Pugliesi, 2011, Current topics in medicinal chemistry.

Modulation of PAR1 signalling by benzimidazole compounds

S. Taliani, M. Trincavelli, C. Martini, 2012, British journal of pharmacology.

Allosteric modulators of human A2B adenosine receptor.

E. Novellino, B. Cosimelli, G. Greco, 2014, Biochimica et biophysica acta.

Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivatives.

E. Novellino, B. Cosimelli, G. Greco, 2013, European journal of medicinal chemistry.

Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors.

Y. Pommier, E. Novellino, F. Da Settimo, 2013, Journal of medicinal chemistry.

Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands.

Talakad G. Lohith, E. Rabiner, R. Gunn, 2011, Journal of medicinal chemistry.